Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Clinical Breast Cancer|April 23, 2018
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast CancerPatrick G Morris, Selene Rota, Karen Cadoo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancerFrancisco J Esteva, John Glaspy, Said Baidas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100Bryan P Schneider, Molin Wang, Milan Radovich, et al.Clinical Breast Cancer|October 28, 2008
Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasibleChau Dang, Gabriella D'Andrea, Diana Lake, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinibPatrick G Morris, Carol Chen, Richard Steingart, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fractionPatrick G Morris, Maura Dickler, Heather L McArthur, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerChau Dang, Neil Iyengar, Farrah Datko, et al.Cancer|January 19, 2012
Augmenting advance care planning in poor prognosis cancer with a video decision aid: a preintervention-postintervention studyAngelo E Volandes, Tomer T Levin, Susan Slovin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancerChau Dang, Monica Fornier, Steven Sugarman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2018
Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)Mark Jesus M Magbanua, Hope S Rugo, Denise M Wolf, et al.Pageof 5